Ademi LLP indicates that an investigation is underway to determine whether the proposed transaction in which Robinson acquires RXO provides fair value to the shareholders of RXO common stock, and whether the board of directors of RXO adequately protected the interests of shareholders during the negotiation and approval of the transaction.
According to the original text, RXO shareholders will receive $17.25 in cash and 0.0856 shares of C.H Robinson Worldwide common stock for each share of RXO stock. Calculated based on the transaction disclosure, the implied total consideration is $30.25 per share, with a transaction valuation of approximately $5.8 billion.
Ademi LLP is still investigating the following matters:
- Is the exchange ratio sufficient to reflect the value and future prospects of RXO;
- Significant control changes related to transactions that can be obtained by insiders of RXO;
- Restrictions on competitive transactions, including significant liquidation fees that may prevent other potential buyers from making better offers;
- The behavior of the board of directors during the negotiation and approval process of the transaction, as well as whether the board of directors fulfilled its responsibilities to the public shareholders.
Ademi LLP indicates that shareholders of RXO who hold RXO stocks may contact them regarding such transactions and their own rights. It is noted that there is no charge for such consultations, nor is there any obligation to provide them.
Contact information is Guri Ademi, phone number 866-264-3995, email [ email protected ].
According to Ademi LLP, its agents are involved in mergers and acquisitions, privatizations, as well as investor lawsuits regarding the rights of individual shareholders.
It is noted in the original text: This is an attorney advertisement; past results cannot guarantee similar outcomes.
